Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

Conditions: Chronic Limb-Threatening Ischemia Interventions: Device: MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold; Device: Percutaneous Transluminal Angioplasty (PTA) Sponsors: R3 Vascular Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06071429

Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials

More News: Angioplasty | Peripheral Angioplasty | Research